January 29, 2013; 80 (5) Article
Pontocerebellar hypoplasia type 1
Clinical spectrum and relevance of EXOSC3 mutations
Sabine Rudnik-Schöneborn, Jan Senderek, Joanna C. Jen, Gunnar Houge, Pavel Seeman, Alena Puchmajerová, Luitgard Graul-Neumann, Ulrich Seidel, Rudolf Korinthenberg, Janbernd Kirschner, Jürgen Seeger, Monique M. Ryan, Francesco Muntoni, Maja Steinlin, Laszlo Sztriha, Jaume Colomer, Christoph Hübner, Knut Brockmann, Lionel Van Maldergem, Manuel Schiff, Andreas Holzinger, Peter Barth, William Reardon, Michael Yourshaw, Stanley F. Nelson, Thomas Eggermann, Klaus Zerres
First published January 2, 2013, DOI: https://doi.org/10.1212/WNL.0b013e31827f0f66
Sabine Rudnik-Schöneborn
From the Institute of Human Genetics (S.R.-S., J. Senderek, T.E., K.Z.), Medical Faculty, University Hospital Aachen, Germany; Departments of Neurology (J.C.J.), Human Genetics (M.Y., S.F.N.), Pathology & Laboratory Medicine (S.F.N.), and Psychiatry (S.F.N.), University of California, Los Angeles; Center for Medical Genetics and Molecular Medicine (G.H.), Haukeland University Hospital, Bergen, Norway; Department of Child Neurology (P.S.), 2nd Faculty of Medicine, Charles University Prague and University Hospital, Prague; Institute of Biology and Medical Genetics (A.P.), University Hospital Motol, Prague, Czech Republic; Institute of Medical and Human Genetics (L.G.-N.), Department of Pediatrics (U.S.), and Department of Neuropediatrics (C.H.), Charité Universitätsmedizin Berlin, Berlin; Department of Pediatrics (R.K., J.K.), University Medical Center Freiburg, Freiburg; German Clinic for Diagnostics (J. Seeger), Wiesbaden, Germany; Royal Children's Hospital (M.M.R.), Murdoch Childrens Research Institute, University of Melbourne, Australia; UCL Institute of Child Health & Great Ormond Street Hospital for Children (F.M.), London, UK; Department of Neuropediatrics (M. Steinlin), University Children's Hospital Bern, Bern, Switzerland; Department of Pediatrics (L.S.), University of Szeged, Hungary; Unitat de Patologia Neuromuscular (J.C.), Servei de Neurologica, Hospital Sant Joan de Déu, Barcelona, Spain; Department of Pediatrics and Pediatric Neurology (K.B.), Faculty of Medicine, University of Göttingen, Göttingen, Germany; Centre for Human Genetics (L.V.M.), Université de Franche-Comté, Besanςon; Department of Child Neurology and Metabolic Diseases (M. Schiff), Hospital Robert Debré, Paris, France; Department of Pediatrics, Dr. von Haunersches Kinderspital (A.H.), Friedrich-Baur-Institut (J. Senderek), Ludwig-Maximilian-Universität München, Munich, Germany; Division of Pediatric Neurology (P.B.), Emma Children's Hospital/Academic Medical Center, University Hospital Amsterdam, the Netherlands; and Our Lady's Hospital for Sick Children (W.R.), Crumlin, Dublin, Ireland.
Jan Senderek
From the Institute of Human Genetics (S.R.-S., J. Senderek, T.E., K.Z.), Medical Faculty, University Hospital Aachen, Germany; Departments of Neurology (J.C.J.), Human Genetics (M.Y., S.F.N.), Pathology & Laboratory Medicine (S.F.N.), and Psychiatry (S.F.N.), University of California, Los Angeles; Center for Medical Genetics and Molecular Medicine (G.H.), Haukeland University Hospital, Bergen, Norway; Department of Child Neurology (P.S.), 2nd Faculty of Medicine, Charles University Prague and University Hospital, Prague; Institute of Biology and Medical Genetics (A.P.), University Hospital Motol, Prague, Czech Republic; Institute of Medical and Human Genetics (L.G.-N.), Department of Pediatrics (U.S.), and Department of Neuropediatrics (C.H.), Charité Universitätsmedizin Berlin, Berlin; Department of Pediatrics (R.K., J.K.), University Medical Center Freiburg, Freiburg; German Clinic for Diagnostics (J. Seeger), Wiesbaden, Germany; Royal Children's Hospital (M.M.R.), Murdoch Childrens Research Institute, University of Melbourne, Australia; UCL Institute of Child Health & Great Ormond Street Hospital for Children (F.M.), London, UK; Department of Neuropediatrics (M. Steinlin), University Children's Hospital Bern, Bern, Switzerland; Department of Pediatrics (L.S.), University of Szeged, Hungary; Unitat de Patologia Neuromuscular (J.C.), Servei de Neurologica, Hospital Sant Joan de Déu, Barcelona, Spain; Department of Pediatrics and Pediatric Neurology (K.B.), Faculty of Medicine, University of Göttingen, Göttingen, Germany; Centre for Human Genetics (L.V.M.), Université de Franche-Comté, Besanςon; Department of Child Neurology and Metabolic Diseases (M. Schiff), Hospital Robert Debré, Paris, France; Department of Pediatrics, Dr. von Haunersches Kinderspital (A.H.), Friedrich-Baur-Institut (J. Senderek), Ludwig-Maximilian-Universität München, Munich, Germany; Division of Pediatric Neurology (P.B.), Emma Children's Hospital/Academic Medical Center, University Hospital Amsterdam, the Netherlands; and Our Lady's Hospital for Sick Children (W.R.), Crumlin, Dublin, Ireland.
Joanna C. Jen
From the Institute of Human Genetics (S.R.-S., J. Senderek, T.E., K.Z.), Medical Faculty, University Hospital Aachen, Germany; Departments of Neurology (J.C.J.), Human Genetics (M.Y., S.F.N.), Pathology & Laboratory Medicine (S.F.N.), and Psychiatry (S.F.N.), University of California, Los Angeles; Center for Medical Genetics and Molecular Medicine (G.H.), Haukeland University Hospital, Bergen, Norway; Department of Child Neurology (P.S.), 2nd Faculty of Medicine, Charles University Prague and University Hospital, Prague; Institute of Biology and Medical Genetics (A.P.), University Hospital Motol, Prague, Czech Republic; Institute of Medical and Human Genetics (L.G.-N.), Department of Pediatrics (U.S.), and Department of Neuropediatrics (C.H.), Charité Universitätsmedizin Berlin, Berlin; Department of Pediatrics (R.K., J.K.), University Medical Center Freiburg, Freiburg; German Clinic for Diagnostics (J. Seeger), Wiesbaden, Germany; Royal Children's Hospital (M.M.R.), Murdoch Childrens Research Institute, University of Melbourne, Australia; UCL Institute of Child Health & Great Ormond Street Hospital for Children (F.M.), London, UK; Department of Neuropediatrics (M. Steinlin), University Children's Hospital Bern, Bern, Switzerland; Department of Pediatrics (L.S.), University of Szeged, Hungary; Unitat de Patologia Neuromuscular (J.C.), Servei de Neurologica, Hospital Sant Joan de Déu, Barcelona, Spain; Department of Pediatrics and Pediatric Neurology (K.B.), Faculty of Medicine, University of Göttingen, Göttingen, Germany; Centre for Human Genetics (L.V.M.), Université de Franche-Comté, Besanςon; Department of Child Neurology and Metabolic Diseases (M. Schiff), Hospital Robert Debré, Paris, France; Department of Pediatrics, Dr. von Haunersches Kinderspital (A.H.), Friedrich-Baur-Institut (J. Senderek), Ludwig-Maximilian-Universität München, Munich, Germany; Division of Pediatric Neurology (P.B.), Emma Children's Hospital/Academic Medical Center, University Hospital Amsterdam, the Netherlands; and Our Lady's Hospital for Sick Children (W.R.), Crumlin, Dublin, Ireland.
Gunnar Houge
From the Institute of Human Genetics (S.R.-S., J. Senderek, T.E., K.Z.), Medical Faculty, University Hospital Aachen, Germany; Departments of Neurology (J.C.J.), Human Genetics (M.Y., S.F.N.), Pathology & Laboratory Medicine (S.F.N.), and Psychiatry (S.F.N.), University of California, Los Angeles; Center for Medical Genetics and Molecular Medicine (G.H.), Haukeland University Hospital, Bergen, Norway; Department of Child Neurology (P.S.), 2nd Faculty of Medicine, Charles University Prague and University Hospital, Prague; Institute of Biology and Medical Genetics (A.P.), University Hospital Motol, Prague, Czech Republic; Institute of Medical and Human Genetics (L.G.-N.), Department of Pediatrics (U.S.), and Department of Neuropediatrics (C.H.), Charité Universitätsmedizin Berlin, Berlin; Department of Pediatrics (R.K., J.K.), University Medical Center Freiburg, Freiburg; German Clinic for Diagnostics (J. Seeger), Wiesbaden, Germany; Royal Children's Hospital (M.M.R.), Murdoch Childrens Research Institute, University of Melbourne, Australia; UCL Institute of Child Health & Great Ormond Street Hospital for Children (F.M.), London, UK; Department of Neuropediatrics (M. Steinlin), University Children's Hospital Bern, Bern, Switzerland; Department of Pediatrics (L.S.), University of Szeged, Hungary; Unitat de Patologia Neuromuscular (J.C.), Servei de Neurologica, Hospital Sant Joan de Déu, Barcelona, Spain; Department of Pediatrics and Pediatric Neurology (K.B.), Faculty of Medicine, University of Göttingen, Göttingen, Germany; Centre for Human Genetics (L.V.M.), Université de Franche-Comté, Besanςon; Department of Child Neurology and Metabolic Diseases (M. Schiff), Hospital Robert Debré, Paris, France; Department of Pediatrics, Dr. von Haunersches Kinderspital (A.H.), Friedrich-Baur-Institut (J. Senderek), Ludwig-Maximilian-Universität München, Munich, Germany; Division of Pediatric Neurology (P.B.), Emma Children's Hospital/Academic Medical Center, University Hospital Amsterdam, the Netherlands; and Our Lady's Hospital for Sick Children (W.R.), Crumlin, Dublin, Ireland.
Pavel Seeman
From the Institute of Human Genetics (S.R.-S., J. Senderek, T.E., K.Z.), Medical Faculty, University Hospital Aachen, Germany; Departments of Neurology (J.C.J.), Human Genetics (M.Y., S.F.N.), Pathology & Laboratory Medicine (S.F.N.), and Psychiatry (S.F.N.), University of California, Los Angeles; Center for Medical Genetics and Molecular Medicine (G.H.), Haukeland University Hospital, Bergen, Norway; Department of Child Neurology (P.S.), 2nd Faculty of Medicine, Charles University Prague and University Hospital, Prague; Institute of Biology and Medical Genetics (A.P.), University Hospital Motol, Prague, Czech Republic; Institute of Medical and Human Genetics (L.G.-N.), Department of Pediatrics (U.S.), and Department of Neuropediatrics (C.H.), Charité Universitätsmedizin Berlin, Berlin; Department of Pediatrics (R.K., J.K.), University Medical Center Freiburg, Freiburg; German Clinic for Diagnostics (J. Seeger), Wiesbaden, Germany; Royal Children's Hospital (M.M.R.), Murdoch Childrens Research Institute, University of Melbourne, Australia; UCL Institute of Child Health & Great Ormond Street Hospital for Children (F.M.), London, UK; Department of Neuropediatrics (M. Steinlin), University Children's Hospital Bern, Bern, Switzerland; Department of Pediatrics (L.S.), University of Szeged, Hungary; Unitat de Patologia Neuromuscular (J.C.), Servei de Neurologica, Hospital Sant Joan de Déu, Barcelona, Spain; Department of Pediatrics and Pediatric Neurology (K.B.), Faculty of Medicine, University of Göttingen, Göttingen, Germany; Centre for Human Genetics (L.V.M.), Université de Franche-Comté, Besanςon; Department of Child Neurology and Metabolic Diseases (M. Schiff), Hospital Robert Debré, Paris, France; Department of Pediatrics, Dr. von Haunersches Kinderspital (A.H.), Friedrich-Baur-Institut (J. Senderek), Ludwig-Maximilian-Universität München, Munich, Germany; Division of Pediatric Neurology (P.B.), Emma Children's Hospital/Academic Medical Center, University Hospital Amsterdam, the Netherlands; and Our Lady's Hospital for Sick Children (W.R.), Crumlin, Dublin, Ireland.
Alena Puchmajerová
From the Institute of Human Genetics (S.R.-S., J. Senderek, T.E., K.Z.), Medical Faculty, University Hospital Aachen, Germany; Departments of Neurology (J.C.J.), Human Genetics (M.Y., S.F.N.), Pathology & Laboratory Medicine (S.F.N.), and Psychiatry (S.F.N.), University of California, Los Angeles; Center for Medical Genetics and Molecular Medicine (G.H.), Haukeland University Hospital, Bergen, Norway; Department of Child Neurology (P.S.), 2nd Faculty of Medicine, Charles University Prague and University Hospital, Prague; Institute of Biology and Medical Genetics (A.P.), University Hospital Motol, Prague, Czech Republic; Institute of Medical and Human Genetics (L.G.-N.), Department of Pediatrics (U.S.), and Department of Neuropediatrics (C.H.), Charité Universitätsmedizin Berlin, Berlin; Department of Pediatrics (R.K., J.K.), University Medical Center Freiburg, Freiburg; German Clinic for Diagnostics (J. Seeger), Wiesbaden, Germany; Royal Children's Hospital (M.M.R.), Murdoch Childrens Research Institute, University of Melbourne, Australia; UCL Institute of Child Health & Great Ormond Street Hospital for Children (F.M.), London, UK; Department of Neuropediatrics (M. Steinlin), University Children's Hospital Bern, Bern, Switzerland; Department of Pediatrics (L.S.), University of Szeged, Hungary; Unitat de Patologia Neuromuscular (J.C.), Servei de Neurologica, Hospital Sant Joan de Déu, Barcelona, Spain; Department of Pediatrics and Pediatric Neurology (K.B.), Faculty of Medicine, University of Göttingen, Göttingen, Germany; Centre for Human Genetics (L.V.M.), Université de Franche-Comté, Besanςon; Department of Child Neurology and Metabolic Diseases (M. Schiff), Hospital Robert Debré, Paris, France; Department of Pediatrics, Dr. von Haunersches Kinderspital (A.H.), Friedrich-Baur-Institut (J. Senderek), Ludwig-Maximilian-Universität München, Munich, Germany; Division of Pediatric Neurology (P.B.), Emma Children's Hospital/Academic Medical Center, University Hospital Amsterdam, the Netherlands; and Our Lady's Hospital for Sick Children (W.R.), Crumlin, Dublin, Ireland.
Luitgard Graul-Neumann
From the Institute of Human Genetics (S.R.-S., J. Senderek, T.E., K.Z.), Medical Faculty, University Hospital Aachen, Germany; Departments of Neurology (J.C.J.), Human Genetics (M.Y., S.F.N.), Pathology & Laboratory Medicine (S.F.N.), and Psychiatry (S.F.N.), University of California, Los Angeles; Center for Medical Genetics and Molecular Medicine (G.H.), Haukeland University Hospital, Bergen, Norway; Department of Child Neurology (P.S.), 2nd Faculty of Medicine, Charles University Prague and University Hospital, Prague; Institute of Biology and Medical Genetics (A.P.), University Hospital Motol, Prague, Czech Republic; Institute of Medical and Human Genetics (L.G.-N.), Department of Pediatrics (U.S.), and Department of Neuropediatrics (C.H.), Charité Universitätsmedizin Berlin, Berlin; Department of Pediatrics (R.K., J.K.), University Medical Center Freiburg, Freiburg; German Clinic for Diagnostics (J. Seeger), Wiesbaden, Germany; Royal Children's Hospital (M.M.R.), Murdoch Childrens Research Institute, University of Melbourne, Australia; UCL Institute of Child Health & Great Ormond Street Hospital for Children (F.M.), London, UK; Department of Neuropediatrics (M. Steinlin), University Children's Hospital Bern, Bern, Switzerland; Department of Pediatrics (L.S.), University of Szeged, Hungary; Unitat de Patologia Neuromuscular (J.C.), Servei de Neurologica, Hospital Sant Joan de Déu, Barcelona, Spain; Department of Pediatrics and Pediatric Neurology (K.B.), Faculty of Medicine, University of Göttingen, Göttingen, Germany; Centre for Human Genetics (L.V.M.), Université de Franche-Comté, Besanςon; Department of Child Neurology and Metabolic Diseases (M. Schiff), Hospital Robert Debré, Paris, France; Department of Pediatrics, Dr. von Haunersches Kinderspital (A.H.), Friedrich-Baur-Institut (J. Senderek), Ludwig-Maximilian-Universität München, Munich, Germany; Division of Pediatric Neurology (P.B.), Emma Children's Hospital/Academic Medical Center, University Hospital Amsterdam, the Netherlands; and Our Lady's Hospital for Sick Children (W.R.), Crumlin, Dublin, Ireland.
Ulrich Seidel
From the Institute of Human Genetics (S.R.-S., J. Senderek, T.E., K.Z.), Medical Faculty, University Hospital Aachen, Germany; Departments of Neurology (J.C.J.), Human Genetics (M.Y., S.F.N.), Pathology & Laboratory Medicine (S.F.N.), and Psychiatry (S.F.N.), University of California, Los Angeles; Center for Medical Genetics and Molecular Medicine (G.H.), Haukeland University Hospital, Bergen, Norway; Department of Child Neurology (P.S.), 2nd Faculty of Medicine, Charles University Prague and University Hospital, Prague; Institute of Biology and Medical Genetics (A.P.), University Hospital Motol, Prague, Czech Republic; Institute of Medical and Human Genetics (L.G.-N.), Department of Pediatrics (U.S.), and Department of Neuropediatrics (C.H.), Charité Universitätsmedizin Berlin, Berlin; Department of Pediatrics (R.K., J.K.), University Medical Center Freiburg, Freiburg; German Clinic for Diagnostics (J. Seeger), Wiesbaden, Germany; Royal Children's Hospital (M.M.R.), Murdoch Childrens Research Institute, University of Melbourne, Australia; UCL Institute of Child Health & Great Ormond Street Hospital for Children (F.M.), London, UK; Department of Neuropediatrics (M. Steinlin), University Children's Hospital Bern, Bern, Switzerland; Department of Pediatrics (L.S.), University of Szeged, Hungary; Unitat de Patologia Neuromuscular (J.C.), Servei de Neurologica, Hospital Sant Joan de Déu, Barcelona, Spain; Department of Pediatrics and Pediatric Neurology (K.B.), Faculty of Medicine, University of Göttingen, Göttingen, Germany; Centre for Human Genetics (L.V.M.), Université de Franche-Comté, Besanςon; Department of Child Neurology and Metabolic Diseases (M. Schiff), Hospital Robert Debré, Paris, France; Department of Pediatrics, Dr. von Haunersches Kinderspital (A.H.), Friedrich-Baur-Institut (J. Senderek), Ludwig-Maximilian-Universität München, Munich, Germany; Division of Pediatric Neurology (P.B.), Emma Children's Hospital/Academic Medical Center, University Hospital Amsterdam, the Netherlands; and Our Lady's Hospital for Sick Children (W.R.), Crumlin, Dublin, Ireland.
Rudolf Korinthenberg
From the Institute of Human Genetics (S.R.-S., J. Senderek, T.E., K.Z.), Medical Faculty, University Hospital Aachen, Germany; Departments of Neurology (J.C.J.), Human Genetics (M.Y., S.F.N.), Pathology & Laboratory Medicine (S.F.N.), and Psychiatry (S.F.N.), University of California, Los Angeles; Center for Medical Genetics and Molecular Medicine (G.H.), Haukeland University Hospital, Bergen, Norway; Department of Child Neurology (P.S.), 2nd Faculty of Medicine, Charles University Prague and University Hospital, Prague; Institute of Biology and Medical Genetics (A.P.), University Hospital Motol, Prague, Czech Republic; Institute of Medical and Human Genetics (L.G.-N.), Department of Pediatrics (U.S.), and Department of Neuropediatrics (C.H.), Charité Universitätsmedizin Berlin, Berlin; Department of Pediatrics (R.K., J.K.), University Medical Center Freiburg, Freiburg; German Clinic for Diagnostics (J. Seeger), Wiesbaden, Germany; Royal Children's Hospital (M.M.R.), Murdoch Childrens Research Institute, University of Melbourne, Australia; UCL Institute of Child Health & Great Ormond Street Hospital for Children (F.M.), London, UK; Department of Neuropediatrics (M. Steinlin), University Children's Hospital Bern, Bern, Switzerland; Department of Pediatrics (L.S.), University of Szeged, Hungary; Unitat de Patologia Neuromuscular (J.C.), Servei de Neurologica, Hospital Sant Joan de Déu, Barcelona, Spain; Department of Pediatrics and Pediatric Neurology (K.B.), Faculty of Medicine, University of Göttingen, Göttingen, Germany; Centre for Human Genetics (L.V.M.), Université de Franche-Comté, Besanςon; Department of Child Neurology and Metabolic Diseases (M. Schiff), Hospital Robert Debré, Paris, France; Department of Pediatrics, Dr. von Haunersches Kinderspital (A.H.), Friedrich-Baur-Institut (J. Senderek), Ludwig-Maximilian-Universität München, Munich, Germany; Division of Pediatric Neurology (P.B.), Emma Children's Hospital/Academic Medical Center, University Hospital Amsterdam, the Netherlands; and Our Lady's Hospital for Sick Children (W.R.), Crumlin, Dublin, Ireland.
Janbernd Kirschner
From the Institute of Human Genetics (S.R.-S., J. Senderek, T.E., K.Z.), Medical Faculty, University Hospital Aachen, Germany; Departments of Neurology (J.C.J.), Human Genetics (M.Y., S.F.N.), Pathology & Laboratory Medicine (S.F.N.), and Psychiatry (S.F.N.), University of California, Los Angeles; Center for Medical Genetics and Molecular Medicine (G.H.), Haukeland University Hospital, Bergen, Norway; Department of Child Neurology (P.S.), 2nd Faculty of Medicine, Charles University Prague and University Hospital, Prague; Institute of Biology and Medical Genetics (A.P.), University Hospital Motol, Prague, Czech Republic; Institute of Medical and Human Genetics (L.G.-N.), Department of Pediatrics (U.S.), and Department of Neuropediatrics (C.H.), Charité Universitätsmedizin Berlin, Berlin; Department of Pediatrics (R.K., J.K.), University Medical Center Freiburg, Freiburg; German Clinic for Diagnostics (J. Seeger), Wiesbaden, Germany; Royal Children's Hospital (M.M.R.), Murdoch Childrens Research Institute, University of Melbourne, Australia; UCL Institute of Child Health & Great Ormond Street Hospital for Children (F.M.), London, UK; Department of Neuropediatrics (M. Steinlin), University Children's Hospital Bern, Bern, Switzerland; Department of Pediatrics (L.S.), University of Szeged, Hungary; Unitat de Patologia Neuromuscular (J.C.), Servei de Neurologica, Hospital Sant Joan de Déu, Barcelona, Spain; Department of Pediatrics and Pediatric Neurology (K.B.), Faculty of Medicine, University of Göttingen, Göttingen, Germany; Centre for Human Genetics (L.V.M.), Université de Franche-Comté, Besanςon; Department of Child Neurology and Metabolic Diseases (M. Schiff), Hospital Robert Debré, Paris, France; Department of Pediatrics, Dr. von Haunersches Kinderspital (A.H.), Friedrich-Baur-Institut (J. Senderek), Ludwig-Maximilian-Universität München, Munich, Germany; Division of Pediatric Neurology (P.B.), Emma Children's Hospital/Academic Medical Center, University Hospital Amsterdam, the Netherlands; and Our Lady's Hospital for Sick Children (W.R.), Crumlin, Dublin, Ireland.
Jürgen Seeger
From the Institute of Human Genetics (S.R.-S., J. Senderek, T.E., K.Z.), Medical Faculty, University Hospital Aachen, Germany; Departments of Neurology (J.C.J.), Human Genetics (M.Y., S.F.N.), Pathology & Laboratory Medicine (S.F.N.), and Psychiatry (S.F.N.), University of California, Los Angeles; Center for Medical Genetics and Molecular Medicine (G.H.), Haukeland University Hospital, Bergen, Norway; Department of Child Neurology (P.S.), 2nd Faculty of Medicine, Charles University Prague and University Hospital, Prague; Institute of Biology and Medical Genetics (A.P.), University Hospital Motol, Prague, Czech Republic; Institute of Medical and Human Genetics (L.G.-N.), Department of Pediatrics (U.S.), and Department of Neuropediatrics (C.H.), Charité Universitätsmedizin Berlin, Berlin; Department of Pediatrics (R.K., J.K.), University Medical Center Freiburg, Freiburg; German Clinic for Diagnostics (J. Seeger), Wiesbaden, Germany; Royal Children's Hospital (M.M.R.), Murdoch Childrens Research Institute, University of Melbourne, Australia; UCL Institute of Child Health & Great Ormond Street Hospital for Children (F.M.), London, UK; Department of Neuropediatrics (M. Steinlin), University Children's Hospital Bern, Bern, Switzerland; Department of Pediatrics (L.S.), University of Szeged, Hungary; Unitat de Patologia Neuromuscular (J.C.), Servei de Neurologica, Hospital Sant Joan de Déu, Barcelona, Spain; Department of Pediatrics and Pediatric Neurology (K.B.), Faculty of Medicine, University of Göttingen, Göttingen, Germany; Centre for Human Genetics (L.V.M.), Université de Franche-Comté, Besanςon; Department of Child Neurology and Metabolic Diseases (M. Schiff), Hospital Robert Debré, Paris, France; Department of Pediatrics, Dr. von Haunersches Kinderspital (A.H.), Friedrich-Baur-Institut (J. Senderek), Ludwig-Maximilian-Universität München, Munich, Germany; Division of Pediatric Neurology (P.B.), Emma Children's Hospital/Academic Medical Center, University Hospital Amsterdam, the Netherlands; and Our Lady's Hospital for Sick Children (W.R.), Crumlin, Dublin, Ireland.
Monique M. Ryan
From the Institute of Human Genetics (S.R.-S., J. Senderek, T.E., K.Z.), Medical Faculty, University Hospital Aachen, Germany; Departments of Neurology (J.C.J.), Human Genetics (M.Y., S.F.N.), Pathology & Laboratory Medicine (S.F.N.), and Psychiatry (S.F.N.), University of California, Los Angeles; Center for Medical Genetics and Molecular Medicine (G.H.), Haukeland University Hospital, Bergen, Norway; Department of Child Neurology (P.S.), 2nd Faculty of Medicine, Charles University Prague and University Hospital, Prague; Institute of Biology and Medical Genetics (A.P.), University Hospital Motol, Prague, Czech Republic; Institute of Medical and Human Genetics (L.G.-N.), Department of Pediatrics (U.S.), and Department of Neuropediatrics (C.H.), Charité Universitätsmedizin Berlin, Berlin; Department of Pediatrics (R.K., J.K.), University Medical Center Freiburg, Freiburg; German Clinic for Diagnostics (J. Seeger), Wiesbaden, Germany; Royal Children's Hospital (M.M.R.), Murdoch Childrens Research Institute, University of Melbourne, Australia; UCL Institute of Child Health & Great Ormond Street Hospital for Children (F.M.), London, UK; Department of Neuropediatrics (M. Steinlin), University Children's Hospital Bern, Bern, Switzerland; Department of Pediatrics (L.S.), University of Szeged, Hungary; Unitat de Patologia Neuromuscular (J.C.), Servei de Neurologica, Hospital Sant Joan de Déu, Barcelona, Spain; Department of Pediatrics and Pediatric Neurology (K.B.), Faculty of Medicine, University of Göttingen, Göttingen, Germany; Centre for Human Genetics (L.V.M.), Université de Franche-Comté, Besanςon; Department of Child Neurology and Metabolic Diseases (M. Schiff), Hospital Robert Debré, Paris, France; Department of Pediatrics, Dr. von Haunersches Kinderspital (A.H.), Friedrich-Baur-Institut (J. Senderek), Ludwig-Maximilian-Universität München, Munich, Germany; Division of Pediatric Neurology (P.B.), Emma Children's Hospital/Academic Medical Center, University Hospital Amsterdam, the Netherlands; and Our Lady's Hospital for Sick Children (W.R.), Crumlin, Dublin, Ireland.
Francesco Muntoni
From the Institute of Human Genetics (S.R.-S., J. Senderek, T.E., K.Z.), Medical Faculty, University Hospital Aachen, Germany; Departments of Neurology (J.C.J.), Human Genetics (M.Y., S.F.N.), Pathology & Laboratory Medicine (S.F.N.), and Psychiatry (S.F.N.), University of California, Los Angeles; Center for Medical Genetics and Molecular Medicine (G.H.), Haukeland University Hospital, Bergen, Norway; Department of Child Neurology (P.S.), 2nd Faculty of Medicine, Charles University Prague and University Hospital, Prague; Institute of Biology and Medical Genetics (A.P.), University Hospital Motol, Prague, Czech Republic; Institute of Medical and Human Genetics (L.G.-N.), Department of Pediatrics (U.S.), and Department of Neuropediatrics (C.H.), Charité Universitätsmedizin Berlin, Berlin; Department of Pediatrics (R.K., J.K.), University Medical Center Freiburg, Freiburg; German Clinic for Diagnostics (J. Seeger), Wiesbaden, Germany; Royal Children's Hospital (M.M.R.), Murdoch Childrens Research Institute, University of Melbourne, Australia; UCL Institute of Child Health & Great Ormond Street Hospital for Children (F.M.), London, UK; Department of Neuropediatrics (M. Steinlin), University Children's Hospital Bern, Bern, Switzerland; Department of Pediatrics (L.S.), University of Szeged, Hungary; Unitat de Patologia Neuromuscular (J.C.), Servei de Neurologica, Hospital Sant Joan de Déu, Barcelona, Spain; Department of Pediatrics and Pediatric Neurology (K.B.), Faculty of Medicine, University of Göttingen, Göttingen, Germany; Centre for Human Genetics (L.V.M.), Université de Franche-Comté, Besanςon; Department of Child Neurology and Metabolic Diseases (M. Schiff), Hospital Robert Debré, Paris, France; Department of Pediatrics, Dr. von Haunersches Kinderspital (A.H.), Friedrich-Baur-Institut (J. Senderek), Ludwig-Maximilian-Universität München, Munich, Germany; Division of Pediatric Neurology (P.B.), Emma Children's Hospital/Academic Medical Center, University Hospital Amsterdam, the Netherlands; and Our Lady's Hospital for Sick Children (W.R.), Crumlin, Dublin, Ireland.
Maja Steinlin
From the Institute of Human Genetics (S.R.-S., J. Senderek, T.E., K.Z.), Medical Faculty, University Hospital Aachen, Germany; Departments of Neurology (J.C.J.), Human Genetics (M.Y., S.F.N.), Pathology & Laboratory Medicine (S.F.N.), and Psychiatry (S.F.N.), University of California, Los Angeles; Center for Medical Genetics and Molecular Medicine (G.H.), Haukeland University Hospital, Bergen, Norway; Department of Child Neurology (P.S.), 2nd Faculty of Medicine, Charles University Prague and University Hospital, Prague; Institute of Biology and Medical Genetics (A.P.), University Hospital Motol, Prague, Czech Republic; Institute of Medical and Human Genetics (L.G.-N.), Department of Pediatrics (U.S.), and Department of Neuropediatrics (C.H.), Charité Universitätsmedizin Berlin, Berlin; Department of Pediatrics (R.K., J.K.), University Medical Center Freiburg, Freiburg; German Clinic for Diagnostics (J. Seeger), Wiesbaden, Germany; Royal Children's Hospital (M.M.R.), Murdoch Childrens Research Institute, University of Melbourne, Australia; UCL Institute of Child Health & Great Ormond Street Hospital for Children (F.M.), London, UK; Department of Neuropediatrics (M. Steinlin), University Children's Hospital Bern, Bern, Switzerland; Department of Pediatrics (L.S.), University of Szeged, Hungary; Unitat de Patologia Neuromuscular (J.C.), Servei de Neurologica, Hospital Sant Joan de Déu, Barcelona, Spain; Department of Pediatrics and Pediatric Neurology (K.B.), Faculty of Medicine, University of Göttingen, Göttingen, Germany; Centre for Human Genetics (L.V.M.), Université de Franche-Comté, Besanςon; Department of Child Neurology and Metabolic Diseases (M. Schiff), Hospital Robert Debré, Paris, France; Department of Pediatrics, Dr. von Haunersches Kinderspital (A.H.), Friedrich-Baur-Institut (J. Senderek), Ludwig-Maximilian-Universität München, Munich, Germany; Division of Pediatric Neurology (P.B.), Emma Children's Hospital/Academic Medical Center, University Hospital Amsterdam, the Netherlands; and Our Lady's Hospital for Sick Children (W.R.), Crumlin, Dublin, Ireland.
Laszlo Sztriha
From the Institute of Human Genetics (S.R.-S., J. Senderek, T.E., K.Z.), Medical Faculty, University Hospital Aachen, Germany; Departments of Neurology (J.C.J.), Human Genetics (M.Y., S.F.N.), Pathology & Laboratory Medicine (S.F.N.), and Psychiatry (S.F.N.), University of California, Los Angeles; Center for Medical Genetics and Molecular Medicine (G.H.), Haukeland University Hospital, Bergen, Norway; Department of Child Neurology (P.S.), 2nd Faculty of Medicine, Charles University Prague and University Hospital, Prague; Institute of Biology and Medical Genetics (A.P.), University Hospital Motol, Prague, Czech Republic; Institute of Medical and Human Genetics (L.G.-N.), Department of Pediatrics (U.S.), and Department of Neuropediatrics (C.H.), Charité Universitätsmedizin Berlin, Berlin; Department of Pediatrics (R.K., J.K.), University Medical Center Freiburg, Freiburg; German Clinic for Diagnostics (J. Seeger), Wiesbaden, Germany; Royal Children's Hospital (M.M.R.), Murdoch Childrens Research Institute, University of Melbourne, Australia; UCL Institute of Child Health & Great Ormond Street Hospital for Children (F.M.), London, UK; Department of Neuropediatrics (M. Steinlin), University Children's Hospital Bern, Bern, Switzerland; Department of Pediatrics (L.S.), University of Szeged, Hungary; Unitat de Patologia Neuromuscular (J.C.), Servei de Neurologica, Hospital Sant Joan de Déu, Barcelona, Spain; Department of Pediatrics and Pediatric Neurology (K.B.), Faculty of Medicine, University of Göttingen, Göttingen, Germany; Centre for Human Genetics (L.V.M.), Université de Franche-Comté, Besanςon; Department of Child Neurology and Metabolic Diseases (M. Schiff), Hospital Robert Debré, Paris, France; Department of Pediatrics, Dr. von Haunersches Kinderspital (A.H.), Friedrich-Baur-Institut (J. Senderek), Ludwig-Maximilian-Universität München, Munich, Germany; Division of Pediatric Neurology (P.B.), Emma Children's Hospital/Academic Medical Center, University Hospital Amsterdam, the Netherlands; and Our Lady's Hospital for Sick Children (W.R.), Crumlin, Dublin, Ireland.
Jaume Colomer
From the Institute of Human Genetics (S.R.-S., J. Senderek, T.E., K.Z.), Medical Faculty, University Hospital Aachen, Germany; Departments of Neurology (J.C.J.), Human Genetics (M.Y., S.F.N.), Pathology & Laboratory Medicine (S.F.N.), and Psychiatry (S.F.N.), University of California, Los Angeles; Center for Medical Genetics and Molecular Medicine (G.H.), Haukeland University Hospital, Bergen, Norway; Department of Child Neurology (P.S.), 2nd Faculty of Medicine, Charles University Prague and University Hospital, Prague; Institute of Biology and Medical Genetics (A.P.), University Hospital Motol, Prague, Czech Republic; Institute of Medical and Human Genetics (L.G.-N.), Department of Pediatrics (U.S.), and Department of Neuropediatrics (C.H.), Charité Universitätsmedizin Berlin, Berlin; Department of Pediatrics (R.K., J.K.), University Medical Center Freiburg, Freiburg; German Clinic for Diagnostics (J. Seeger), Wiesbaden, Germany; Royal Children's Hospital (M.M.R.), Murdoch Childrens Research Institute, University of Melbourne, Australia; UCL Institute of Child Health & Great Ormond Street Hospital for Children (F.M.), London, UK; Department of Neuropediatrics (M. Steinlin), University Children's Hospital Bern, Bern, Switzerland; Department of Pediatrics (L.S.), University of Szeged, Hungary; Unitat de Patologia Neuromuscular (J.C.), Servei de Neurologica, Hospital Sant Joan de Déu, Barcelona, Spain; Department of Pediatrics and Pediatric Neurology (K.B.), Faculty of Medicine, University of Göttingen, Göttingen, Germany; Centre for Human Genetics (L.V.M.), Université de Franche-Comté, Besanςon; Department of Child Neurology and Metabolic Diseases (M. Schiff), Hospital Robert Debré, Paris, France; Department of Pediatrics, Dr. von Haunersches Kinderspital (A.H.), Friedrich-Baur-Institut (J. Senderek), Ludwig-Maximilian-Universität München, Munich, Germany; Division of Pediatric Neurology (P.B.), Emma Children's Hospital/Academic Medical Center, University Hospital Amsterdam, the Netherlands; and Our Lady's Hospital for Sick Children (W.R.), Crumlin, Dublin, Ireland.
Christoph Hübner
From the Institute of Human Genetics (S.R.-S., J. Senderek, T.E., K.Z.), Medical Faculty, University Hospital Aachen, Germany; Departments of Neurology (J.C.J.), Human Genetics (M.Y., S.F.N.), Pathology & Laboratory Medicine (S.F.N.), and Psychiatry (S.F.N.), University of California, Los Angeles; Center for Medical Genetics and Molecular Medicine (G.H.), Haukeland University Hospital, Bergen, Norway; Department of Child Neurology (P.S.), 2nd Faculty of Medicine, Charles University Prague and University Hospital, Prague; Institute of Biology and Medical Genetics (A.P.), University Hospital Motol, Prague, Czech Republic; Institute of Medical and Human Genetics (L.G.-N.), Department of Pediatrics (U.S.), and Department of Neuropediatrics (C.H.), Charité Universitätsmedizin Berlin, Berlin; Department of Pediatrics (R.K., J.K.), University Medical Center Freiburg, Freiburg; German Clinic for Diagnostics (J. Seeger), Wiesbaden, Germany; Royal Children's Hospital (M.M.R.), Murdoch Childrens Research Institute, University of Melbourne, Australia; UCL Institute of Child Health & Great Ormond Street Hospital for Children (F.M.), London, UK; Department of Neuropediatrics (M. Steinlin), University Children's Hospital Bern, Bern, Switzerland; Department of Pediatrics (L.S.), University of Szeged, Hungary; Unitat de Patologia Neuromuscular (J.C.), Servei de Neurologica, Hospital Sant Joan de Déu, Barcelona, Spain; Department of Pediatrics and Pediatric Neurology (K.B.), Faculty of Medicine, University of Göttingen, Göttingen, Germany; Centre for Human Genetics (L.V.M.), Université de Franche-Comté, Besanςon; Department of Child Neurology and Metabolic Diseases (M. Schiff), Hospital Robert Debré, Paris, France; Department of Pediatrics, Dr. von Haunersches Kinderspital (A.H.), Friedrich-Baur-Institut (J. Senderek), Ludwig-Maximilian-Universität München, Munich, Germany; Division of Pediatric Neurology (P.B.), Emma Children's Hospital/Academic Medical Center, University Hospital Amsterdam, the Netherlands; and Our Lady's Hospital for Sick Children (W.R.), Crumlin, Dublin, Ireland.
Knut Brockmann
From the Institute of Human Genetics (S.R.-S., J. Senderek, T.E., K.Z.), Medical Faculty, University Hospital Aachen, Germany; Departments of Neurology (J.C.J.), Human Genetics (M.Y., S.F.N.), Pathology & Laboratory Medicine (S.F.N.), and Psychiatry (S.F.N.), University of California, Los Angeles; Center for Medical Genetics and Molecular Medicine (G.H.), Haukeland University Hospital, Bergen, Norway; Department of Child Neurology (P.S.), 2nd Faculty of Medicine, Charles University Prague and University Hospital, Prague; Institute of Biology and Medical Genetics (A.P.), University Hospital Motol, Prague, Czech Republic; Institute of Medical and Human Genetics (L.G.-N.), Department of Pediatrics (U.S.), and Department of Neuropediatrics (C.H.), Charité Universitätsmedizin Berlin, Berlin; Department of Pediatrics (R.K., J.K.), University Medical Center Freiburg, Freiburg; German Clinic for Diagnostics (J. Seeger), Wiesbaden, Germany; Royal Children's Hospital (M.M.R.), Murdoch Childrens Research Institute, University of Melbourne, Australia; UCL Institute of Child Health & Great Ormond Street Hospital for Children (F.M.), London, UK; Department of Neuropediatrics (M. Steinlin), University Children's Hospital Bern, Bern, Switzerland; Department of Pediatrics (L.S.), University of Szeged, Hungary; Unitat de Patologia Neuromuscular (J.C.), Servei de Neurologica, Hospital Sant Joan de Déu, Barcelona, Spain; Department of Pediatrics and Pediatric Neurology (K.B.), Faculty of Medicine, University of Göttingen, Göttingen, Germany; Centre for Human Genetics (L.V.M.), Université de Franche-Comté, Besanςon; Department of Child Neurology and Metabolic Diseases (M. Schiff), Hospital Robert Debré, Paris, France; Department of Pediatrics, Dr. von Haunersches Kinderspital (A.H.), Friedrich-Baur-Institut (J. Senderek), Ludwig-Maximilian-Universität München, Munich, Germany; Division of Pediatric Neurology (P.B.), Emma Children's Hospital/Academic Medical Center, University Hospital Amsterdam, the Netherlands; and Our Lady's Hospital for Sick Children (W.R.), Crumlin, Dublin, Ireland.
Lionel Van Maldergem
From the Institute of Human Genetics (S.R.-S., J. Senderek, T.E., K.Z.), Medical Faculty, University Hospital Aachen, Germany; Departments of Neurology (J.C.J.), Human Genetics (M.Y., S.F.N.), Pathology & Laboratory Medicine (S.F.N.), and Psychiatry (S.F.N.), University of California, Los Angeles; Center for Medical Genetics and Molecular Medicine (G.H.), Haukeland University Hospital, Bergen, Norway; Department of Child Neurology (P.S.), 2nd Faculty of Medicine, Charles University Prague and University Hospital, Prague; Institute of Biology and Medical Genetics (A.P.), University Hospital Motol, Prague, Czech Republic; Institute of Medical and Human Genetics (L.G.-N.), Department of Pediatrics (U.S.), and Department of Neuropediatrics (C.H.), Charité Universitätsmedizin Berlin, Berlin; Department of Pediatrics (R.K., J.K.), University Medical Center Freiburg, Freiburg; German Clinic for Diagnostics (J. Seeger), Wiesbaden, Germany; Royal Children's Hospital (M.M.R.), Murdoch Childrens Research Institute, University of Melbourne, Australia; UCL Institute of Child Health & Great Ormond Street Hospital for Children (F.M.), London, UK; Department of Neuropediatrics (M. Steinlin), University Children's Hospital Bern, Bern, Switzerland; Department of Pediatrics (L.S.), University of Szeged, Hungary; Unitat de Patologia Neuromuscular (J.C.), Servei de Neurologica, Hospital Sant Joan de Déu, Barcelona, Spain; Department of Pediatrics and Pediatric Neurology (K.B.), Faculty of Medicine, University of Göttingen, Göttingen, Germany; Centre for Human Genetics (L.V.M.), Université de Franche-Comté, Besanςon; Department of Child Neurology and Metabolic Diseases (M. Schiff), Hospital Robert Debré, Paris, France; Department of Pediatrics, Dr. von Haunersches Kinderspital (A.H.), Friedrich-Baur-Institut (J. Senderek), Ludwig-Maximilian-Universität München, Munich, Germany; Division of Pediatric Neurology (P.B.), Emma Children's Hospital/Academic Medical Center, University Hospital Amsterdam, the Netherlands; and Our Lady's Hospital for Sick Children (W.R.), Crumlin, Dublin, Ireland.
Manuel Schiff
From the Institute of Human Genetics (S.R.-S., J. Senderek, T.E., K.Z.), Medical Faculty, University Hospital Aachen, Germany; Departments of Neurology (J.C.J.), Human Genetics (M.Y., S.F.N.), Pathology & Laboratory Medicine (S.F.N.), and Psychiatry (S.F.N.), University of California, Los Angeles; Center for Medical Genetics and Molecular Medicine (G.H.), Haukeland University Hospital, Bergen, Norway; Department of Child Neurology (P.S.), 2nd Faculty of Medicine, Charles University Prague and University Hospital, Prague; Institute of Biology and Medical Genetics (A.P.), University Hospital Motol, Prague, Czech Republic; Institute of Medical and Human Genetics (L.G.-N.), Department of Pediatrics (U.S.), and Department of Neuropediatrics (C.H.), Charité Universitätsmedizin Berlin, Berlin; Department of Pediatrics (R.K., J.K.), University Medical Center Freiburg, Freiburg; German Clinic for Diagnostics (J. Seeger), Wiesbaden, Germany; Royal Children's Hospital (M.M.R.), Murdoch Childrens Research Institute, University of Melbourne, Australia; UCL Institute of Child Health & Great Ormond Street Hospital for Children (F.M.), London, UK; Department of Neuropediatrics (M. Steinlin), University Children's Hospital Bern, Bern, Switzerland; Department of Pediatrics (L.S.), University of Szeged, Hungary; Unitat de Patologia Neuromuscular (J.C.), Servei de Neurologica, Hospital Sant Joan de Déu, Barcelona, Spain; Department of Pediatrics and Pediatric Neurology (K.B.), Faculty of Medicine, University of Göttingen, Göttingen, Germany; Centre for Human Genetics (L.V.M.), Université de Franche-Comté, Besanςon; Department of Child Neurology and Metabolic Diseases (M. Schiff), Hospital Robert Debré, Paris, France; Department of Pediatrics, Dr. von Haunersches Kinderspital (A.H.), Friedrich-Baur-Institut (J. Senderek), Ludwig-Maximilian-Universität München, Munich, Germany; Division of Pediatric Neurology (P.B.), Emma Children's Hospital/Academic Medical Center, University Hospital Amsterdam, the Netherlands; and Our Lady's Hospital for Sick Children (W.R.), Crumlin, Dublin, Ireland.
Andreas Holzinger
From the Institute of Human Genetics (S.R.-S., J. Senderek, T.E., K.Z.), Medical Faculty, University Hospital Aachen, Germany; Departments of Neurology (J.C.J.), Human Genetics (M.Y., S.F.N.), Pathology & Laboratory Medicine (S.F.N.), and Psychiatry (S.F.N.), University of California, Los Angeles; Center for Medical Genetics and Molecular Medicine (G.H.), Haukeland University Hospital, Bergen, Norway; Department of Child Neurology (P.S.), 2nd Faculty of Medicine, Charles University Prague and University Hospital, Prague; Institute of Biology and Medical Genetics (A.P.), University Hospital Motol, Prague, Czech Republic; Institute of Medical and Human Genetics (L.G.-N.), Department of Pediatrics (U.S.), and Department of Neuropediatrics (C.H.), Charité Universitätsmedizin Berlin, Berlin; Department of Pediatrics (R.K., J.K.), University Medical Center Freiburg, Freiburg; German Clinic for Diagnostics (J. Seeger), Wiesbaden, Germany; Royal Children's Hospital (M.M.R.), Murdoch Childrens Research Institute, University of Melbourne, Australia; UCL Institute of Child Health & Great Ormond Street Hospital for Children (F.M.), London, UK; Department of Neuropediatrics (M. Steinlin), University Children's Hospital Bern, Bern, Switzerland; Department of Pediatrics (L.S.), University of Szeged, Hungary; Unitat de Patologia Neuromuscular (J.C.), Servei de Neurologica, Hospital Sant Joan de Déu, Barcelona, Spain; Department of Pediatrics and Pediatric Neurology (K.B.), Faculty of Medicine, University of Göttingen, Göttingen, Germany; Centre for Human Genetics (L.V.M.), Université de Franche-Comté, Besanςon; Department of Child Neurology and Metabolic Diseases (M. Schiff), Hospital Robert Debré, Paris, France; Department of Pediatrics, Dr. von Haunersches Kinderspital (A.H.), Friedrich-Baur-Institut (J. Senderek), Ludwig-Maximilian-Universität München, Munich, Germany; Division of Pediatric Neurology (P.B.), Emma Children's Hospital/Academic Medical Center, University Hospital Amsterdam, the Netherlands; and Our Lady's Hospital for Sick Children (W.R.), Crumlin, Dublin, Ireland.
Peter Barth
From the Institute of Human Genetics (S.R.-S., J. Senderek, T.E., K.Z.), Medical Faculty, University Hospital Aachen, Germany; Departments of Neurology (J.C.J.), Human Genetics (M.Y., S.F.N.), Pathology & Laboratory Medicine (S.F.N.), and Psychiatry (S.F.N.), University of California, Los Angeles; Center for Medical Genetics and Molecular Medicine (G.H.), Haukeland University Hospital, Bergen, Norway; Department of Child Neurology (P.S.), 2nd Faculty of Medicine, Charles University Prague and University Hospital, Prague; Institute of Biology and Medical Genetics (A.P.), University Hospital Motol, Prague, Czech Republic; Institute of Medical and Human Genetics (L.G.-N.), Department of Pediatrics (U.S.), and Department of Neuropediatrics (C.H.), Charité Universitätsmedizin Berlin, Berlin; Department of Pediatrics (R.K., J.K.), University Medical Center Freiburg, Freiburg; German Clinic for Diagnostics (J. Seeger), Wiesbaden, Germany; Royal Children's Hospital (M.M.R.), Murdoch Childrens Research Institute, University of Melbourne, Australia; UCL Institute of Child Health & Great Ormond Street Hospital for Children (F.M.), London, UK; Department of Neuropediatrics (M. Steinlin), University Children's Hospital Bern, Bern, Switzerland; Department of Pediatrics (L.S.), University of Szeged, Hungary; Unitat de Patologia Neuromuscular (J.C.), Servei de Neurologica, Hospital Sant Joan de Déu, Barcelona, Spain; Department of Pediatrics and Pediatric Neurology (K.B.), Faculty of Medicine, University of Göttingen, Göttingen, Germany; Centre for Human Genetics (L.V.M.), Université de Franche-Comté, Besanςon; Department of Child Neurology and Metabolic Diseases (M. Schiff), Hospital Robert Debré, Paris, France; Department of Pediatrics, Dr. von Haunersches Kinderspital (A.H.), Friedrich-Baur-Institut (J. Senderek), Ludwig-Maximilian-Universität München, Munich, Germany; Division of Pediatric Neurology (P.B.), Emma Children's Hospital/Academic Medical Center, University Hospital Amsterdam, the Netherlands; and Our Lady's Hospital for Sick Children (W.R.), Crumlin, Dublin, Ireland.
William Reardon
From the Institute of Human Genetics (S.R.-S., J. Senderek, T.E., K.Z.), Medical Faculty, University Hospital Aachen, Germany; Departments of Neurology (J.C.J.), Human Genetics (M.Y., S.F.N.), Pathology & Laboratory Medicine (S.F.N.), and Psychiatry (S.F.N.), University of California, Los Angeles; Center for Medical Genetics and Molecular Medicine (G.H.), Haukeland University Hospital, Bergen, Norway; Department of Child Neurology (P.S.), 2nd Faculty of Medicine, Charles University Prague and University Hospital, Prague; Institute of Biology and Medical Genetics (A.P.), University Hospital Motol, Prague, Czech Republic; Institute of Medical and Human Genetics (L.G.-N.), Department of Pediatrics (U.S.), and Department of Neuropediatrics (C.H.), Charité Universitätsmedizin Berlin, Berlin; Department of Pediatrics (R.K., J.K.), University Medical Center Freiburg, Freiburg; German Clinic for Diagnostics (J. Seeger), Wiesbaden, Germany; Royal Children's Hospital (M.M.R.), Murdoch Childrens Research Institute, University of Melbourne, Australia; UCL Institute of Child Health & Great Ormond Street Hospital for Children (F.M.), London, UK; Department of Neuropediatrics (M. Steinlin), University Children's Hospital Bern, Bern, Switzerland; Department of Pediatrics (L.S.), University of Szeged, Hungary; Unitat de Patologia Neuromuscular (J.C.), Servei de Neurologica, Hospital Sant Joan de Déu, Barcelona, Spain; Department of Pediatrics and Pediatric Neurology (K.B.), Faculty of Medicine, University of Göttingen, Göttingen, Germany; Centre for Human Genetics (L.V.M.), Université de Franche-Comté, Besanςon; Department of Child Neurology and Metabolic Diseases (M. Schiff), Hospital Robert Debré, Paris, France; Department of Pediatrics, Dr. von Haunersches Kinderspital (A.H.), Friedrich-Baur-Institut (J. Senderek), Ludwig-Maximilian-Universität München, Munich, Germany; Division of Pediatric Neurology (P.B.), Emma Children's Hospital/Academic Medical Center, University Hospital Amsterdam, the Netherlands; and Our Lady's Hospital for Sick Children (W.R.), Crumlin, Dublin, Ireland.
Michael Yourshaw
From the Institute of Human Genetics (S.R.-S., J. Senderek, T.E., K.Z.), Medical Faculty, University Hospital Aachen, Germany; Departments of Neurology (J.C.J.), Human Genetics (M.Y., S.F.N.), Pathology & Laboratory Medicine (S.F.N.), and Psychiatry (S.F.N.), University of California, Los Angeles; Center for Medical Genetics and Molecular Medicine (G.H.), Haukeland University Hospital, Bergen, Norway; Department of Child Neurology (P.S.), 2nd Faculty of Medicine, Charles University Prague and University Hospital, Prague; Institute of Biology and Medical Genetics (A.P.), University Hospital Motol, Prague, Czech Republic; Institute of Medical and Human Genetics (L.G.-N.), Department of Pediatrics (U.S.), and Department of Neuropediatrics (C.H.), Charité Universitätsmedizin Berlin, Berlin; Department of Pediatrics (R.K., J.K.), University Medical Center Freiburg, Freiburg; German Clinic for Diagnostics (J. Seeger), Wiesbaden, Germany; Royal Children's Hospital (M.M.R.), Murdoch Childrens Research Institute, University of Melbourne, Australia; UCL Institute of Child Health & Great Ormond Street Hospital for Children (F.M.), London, UK; Department of Neuropediatrics (M. Steinlin), University Children's Hospital Bern, Bern, Switzerland; Department of Pediatrics (L.S.), University of Szeged, Hungary; Unitat de Patologia Neuromuscular (J.C.), Servei de Neurologica, Hospital Sant Joan de Déu, Barcelona, Spain; Department of Pediatrics and Pediatric Neurology (K.B.), Faculty of Medicine, University of Göttingen, Göttingen, Germany; Centre for Human Genetics (L.V.M.), Université de Franche-Comté, Besanςon; Department of Child Neurology and Metabolic Diseases (M. Schiff), Hospital Robert Debré, Paris, France; Department of Pediatrics, Dr. von Haunersches Kinderspital (A.H.), Friedrich-Baur-Institut (J. Senderek), Ludwig-Maximilian-Universität München, Munich, Germany; Division of Pediatric Neurology (P.B.), Emma Children's Hospital/Academic Medical Center, University Hospital Amsterdam, the Netherlands; and Our Lady's Hospital for Sick Children (W.R.), Crumlin, Dublin, Ireland.
Stanley F. Nelson
From the Institute of Human Genetics (S.R.-S., J. Senderek, T.E., K.Z.), Medical Faculty, University Hospital Aachen, Germany; Departments of Neurology (J.C.J.), Human Genetics (M.Y., S.F.N.), Pathology & Laboratory Medicine (S.F.N.), and Psychiatry (S.F.N.), University of California, Los Angeles; Center for Medical Genetics and Molecular Medicine (G.H.), Haukeland University Hospital, Bergen, Norway; Department of Child Neurology (P.S.), 2nd Faculty of Medicine, Charles University Prague and University Hospital, Prague; Institute of Biology and Medical Genetics (A.P.), University Hospital Motol, Prague, Czech Republic; Institute of Medical and Human Genetics (L.G.-N.), Department of Pediatrics (U.S.), and Department of Neuropediatrics (C.H.), Charité Universitätsmedizin Berlin, Berlin; Department of Pediatrics (R.K., J.K.), University Medical Center Freiburg, Freiburg; German Clinic for Diagnostics (J. Seeger), Wiesbaden, Germany; Royal Children's Hospital (M.M.R.), Murdoch Childrens Research Institute, University of Melbourne, Australia; UCL Institute of Child Health & Great Ormond Street Hospital for Children (F.M.), London, UK; Department of Neuropediatrics (M. Steinlin), University Children's Hospital Bern, Bern, Switzerland; Department of Pediatrics (L.S.), University of Szeged, Hungary; Unitat de Patologia Neuromuscular (J.C.), Servei de Neurologica, Hospital Sant Joan de Déu, Barcelona, Spain; Department of Pediatrics and Pediatric Neurology (K.B.), Faculty of Medicine, University of Göttingen, Göttingen, Germany; Centre for Human Genetics (L.V.M.), Université de Franche-Comté, Besanςon; Department of Child Neurology and Metabolic Diseases (M. Schiff), Hospital Robert Debré, Paris, France; Department of Pediatrics, Dr. von Haunersches Kinderspital (A.H.), Friedrich-Baur-Institut (J. Senderek), Ludwig-Maximilian-Universität München, Munich, Germany; Division of Pediatric Neurology (P.B.), Emma Children's Hospital/Academic Medical Center, University Hospital Amsterdam, the Netherlands; and Our Lady's Hospital for Sick Children (W.R.), Crumlin, Dublin, Ireland.
Thomas Eggermann
From the Institute of Human Genetics (S.R.-S., J. Senderek, T.E., K.Z.), Medical Faculty, University Hospital Aachen, Germany; Departments of Neurology (J.C.J.), Human Genetics (M.Y., S.F.N.), Pathology & Laboratory Medicine (S.F.N.), and Psychiatry (S.F.N.), University of California, Los Angeles; Center for Medical Genetics and Molecular Medicine (G.H.), Haukeland University Hospital, Bergen, Norway; Department of Child Neurology (P.S.), 2nd Faculty of Medicine, Charles University Prague and University Hospital, Prague; Institute of Biology and Medical Genetics (A.P.), University Hospital Motol, Prague, Czech Republic; Institute of Medical and Human Genetics (L.G.-N.), Department of Pediatrics (U.S.), and Department of Neuropediatrics (C.H.), Charité Universitätsmedizin Berlin, Berlin; Department of Pediatrics (R.K., J.K.), University Medical Center Freiburg, Freiburg; German Clinic for Diagnostics (J. Seeger), Wiesbaden, Germany; Royal Children's Hospital (M.M.R.), Murdoch Childrens Research Institute, University of Melbourne, Australia; UCL Institute of Child Health & Great Ormond Street Hospital for Children (F.M.), London, UK; Department of Neuropediatrics (M. Steinlin), University Children's Hospital Bern, Bern, Switzerland; Department of Pediatrics (L.S.), University of Szeged, Hungary; Unitat de Patologia Neuromuscular (J.C.), Servei de Neurologica, Hospital Sant Joan de Déu, Barcelona, Spain; Department of Pediatrics and Pediatric Neurology (K.B.), Faculty of Medicine, University of Göttingen, Göttingen, Germany; Centre for Human Genetics (L.V.M.), Université de Franche-Comté, Besanςon; Department of Child Neurology and Metabolic Diseases (M. Schiff), Hospital Robert Debré, Paris, France; Department of Pediatrics, Dr. von Haunersches Kinderspital (A.H.), Friedrich-Baur-Institut (J. Senderek), Ludwig-Maximilian-Universität München, Munich, Germany; Division of Pediatric Neurology (P.B.), Emma Children's Hospital/Academic Medical Center, University Hospital Amsterdam, the Netherlands; and Our Lady's Hospital for Sick Children (W.R.), Crumlin, Dublin, Ireland.
Klaus Zerres
From the Institute of Human Genetics (S.R.-S., J. Senderek, T.E., K.Z.), Medical Faculty, University Hospital Aachen, Germany; Departments of Neurology (J.C.J.), Human Genetics (M.Y., S.F.N.), Pathology & Laboratory Medicine (S.F.N.), and Psychiatry (S.F.N.), University of California, Los Angeles; Center for Medical Genetics and Molecular Medicine (G.H.), Haukeland University Hospital, Bergen, Norway; Department of Child Neurology (P.S.), 2nd Faculty of Medicine, Charles University Prague and University Hospital, Prague; Institute of Biology and Medical Genetics (A.P.), University Hospital Motol, Prague, Czech Republic; Institute of Medical and Human Genetics (L.G.-N.), Department of Pediatrics (U.S.), and Department of Neuropediatrics (C.H.), Charité Universitätsmedizin Berlin, Berlin; Department of Pediatrics (R.K., J.K.), University Medical Center Freiburg, Freiburg; German Clinic for Diagnostics (J. Seeger), Wiesbaden, Germany; Royal Children's Hospital (M.M.R.), Murdoch Childrens Research Institute, University of Melbourne, Australia; UCL Institute of Child Health & Great Ormond Street Hospital for Children (F.M.), London, UK; Department of Neuropediatrics (M. Steinlin), University Children's Hospital Bern, Bern, Switzerland; Department of Pediatrics (L.S.), University of Szeged, Hungary; Unitat de Patologia Neuromuscular (J.C.), Servei de Neurologica, Hospital Sant Joan de Déu, Barcelona, Spain; Department of Pediatrics and Pediatric Neurology (K.B.), Faculty of Medicine, University of Göttingen, Göttingen, Germany; Centre for Human Genetics (L.V.M.), Université de Franche-Comté, Besanςon; Department of Child Neurology and Metabolic Diseases (M. Schiff), Hospital Robert Debré, Paris, France; Department of Pediatrics, Dr. von Haunersches Kinderspital (A.H.), Friedrich-Baur-Institut (J. Senderek), Ludwig-Maximilian-Universität München, Munich, Germany; Division of Pediatric Neurology (P.B.), Emma Children's Hospital/Academic Medical Center, University Hospital Amsterdam, the Netherlands; and Our Lady's Hospital for Sick Children (W.R.), Crumlin, Dublin, Ireland.
Pontocerebellar hypoplasia type 1
Clinical spectrum and relevance of EXOSC3 mutations
Sabine Rudnik-Schöneborn, Jan Senderek, Joanna C. Jen, Gunnar Houge, Pavel Seeman, Alena Puchmajerová, Luitgard Graul-Neumann, Ulrich Seidel, Rudolf Korinthenberg, Janbernd Kirschner, Jürgen Seeger, Monique M. Ryan, Francesco Muntoni, Maja Steinlin, Laszlo Sztriha, Jaume Colomer, Christoph Hübner, Knut Brockmann, Lionel Van Maldergem, Manuel Schiff, Andreas Holzinger, Peter Barth, William Reardon, Michael Yourshaw, Stanley F. Nelson, Thomas Eggermann, Klaus Zerres
Neurology Jan 2013, 80 (5) 438-446; DOI: 10.1212/WNL.0b013e31827f0f66
Citation Manager Formats
Make Comment
See Comments
Downloads
923
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objectives: Pontocerebellar hypoplasia with spinal muscular atrophy, also known as PCH1, is a group of autosomal recessive disorders characterized by generalized muscle weakness and global developmental delay commonly resulting in early death. Gene defects had been discovered only in single patients until the recent identification of EXOSC3 mutations in several families with relatively mild course of PCH1. We aim to genetically stratify subjects in a large and well-defined cohort to define the clinical spectrum and genotype–phenotype correlation.
Methods: We documented clinical, neuroimaging, and morphologic data of 37 subjects from 27 families with PCH1. EXOSC3 gene sequencing was performed in 27 unrelated index patients of mixed ethnicity.
Results: Biallelic mutations in EXOSC3 were detected in 10 of 27 families (37%). The most common mutation among all ethnic groups was c.395A>C, p.D132A, responsible for 11 (55%) of the 20 mutated alleles and ancestral in origin. The mutation-positive subjects typically presented with normal pregnancy, normal birth measurements, and relative preservation of brainstem and cortical structures. Psychomotor retardation was profound in all patients but lifespan was variable, with 3 subjects surviving beyond the late teens. Abnormal oculomotor function was commonly observed in patients surviving beyond the first year. Major clinical features previously reported in PCH1, including intrauterine abnormalities, postnatal hypoventilation and feeding difficulties, joint contractures, and neonatal death, were rarely observed in mutation-positive infants but were typical among the mutation-negative subjects.
Conclusion: EXOSC3 mutations account for 30%–40% of patients with PCH1 with variability in survival and clinical severity that is correlated with the genotype.
GLOSSARY
- EXOSC3=
- exosome component 3;
- PCH=
- pontocerebellar hypoplasia;
- PCH1=
- pontocerebellar hypoplasia with spinal muscular atrophy;
- RRP40=
- ribosomal RNA–processing protein 40;
- SMA=
- spinal muscular atrophy
Footnotes
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
Supplemental data at www.neurology.org
Editorial, page 426
- Received May 25, 2012.
- Accepted October 5, 2012.
- © 2013 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Efficacy of Ubrogepant in the Acute Treatment of Migraine With Mild Pain vs Moderate or Severe Pain
Dr. Kathleen Digre and Dr. Kendra Pham
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Editorial
Defects of RNA metabolism in the pathogenesis of spinal muscular atrophyEnrico Bertini, Henry Houlden et al.Neurology, March 19, 2014 -
Articles
Preimplantation genetic diagnosis for spinal muscular atrophy type IL. Fallon, G.L. Harton, M.E. Sisson et al.Neurology, September 01, 1999 -
Articles
SMN1 gene, but not SMN2, is a risk factor for sporadic ALSP. Corcia, W. Camu, J. -M. Halimi et al.Neurology, August 23, 2006 -
Articles
Genotype-phenotype relationship in 2 SMA III patients with novel mutations in the Tudor domainM.J. Fraidakis, S. Drunat, T. Maisonobe et al.Neurology, February 08, 2012